GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00252876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 107-week open-label, multi-center long-term extension study from GALLANT studies 2/22, 5, 7, 8 and 14 to monitor the safety and tolerability of oral tesaglitazar 1 mg in patients with type 2 diabetes during up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.
Study identification
- NCT ID
- NCT00252876
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Jan 2007 (Actual)
- Last update posted
- Mar 17, 2008
2005 – 2007
United States locations
- U.S. sites
- 58
- U.S. states
- 28
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Columbiana | Alabama | — | — |
| Research Site | Mobile | Alabama | — | — |
| Research Site | Carlisle | Arkansas | — | — |
| Research Site | Sherwood | Arkansas | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Escondido | California | — | — |
| Research Site | Huntington Beach | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Mission Viejo | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Pasadena | California | — | — |
| Research Site | Redondo Beach | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Wheat Ridge | Colorado | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Brunswick | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Evansville | Indiana | — | — |
| Research Site | Witchita | Kansas | — | — |
| Research Site | Bossier City | Louisiana | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Kalamazoo | Michigan | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Pahrump | Nevada | — | — |
| Research Site | Hamilton | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | White Plains | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Kettering | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Simpsonville | South Carolina | — | — |
| Research Site | Morristown | Tennessee | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Menomonee Falls | Wisconsin | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 219 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00252876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2008 · Synced Oct 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00252876 live on ClinicalTrials.gov.